ArticleCMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne2021
Improving the regulation of medical cannabis in Canada to better serve pediatric patients.
Abstract read
In one paragraph
Article in CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- School Nurse Perspectives of Medical Cannabis Policy in K-12 Schools: An Exploratory Descriptive Study.The Journal of school nursing : the official publication of the National Association of School Nurses · 2024Article
- Les données probantes et les recommandations sur le cannabis à des fins médicales chez les enfants.Paediatrics & child health · 2024Review
- Medical cannabis for children: Evidence and recommendations.Paediatrics & child health · 2024Review
- Removing barriers to accessing medical cannabis for paediatric patients.Paediatrics & child health · 2024Article
- Article
- Why a distinct medical stream is necessary to support patients using cannabis for medical purposes.Journal of cannabis research · 2023Article
- Evaluating the Supporting Evidence of Medical Cannabis Claims Made on Clinic Websites: Cross-Sectional Study.Journal of medical Internet research · 2023Article
- Exploring Clinicians' Determinants of Participation in Medical Cannabis Decision Making with Older Adults Experiencing Arthritis: A Qualitative Descriptive Study.MDM policy & practiceArticle
- Use of Cannabis-Based Medical Products for Pediatric Health Conditions: A Systematic Review of the Recent Literature.Medical cannabis and cannabinoidsReview
- An examination of cannabis-related information typically asked by consumers at retail cannabis locations: A Canadian survey of budtenders and managers.Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPCArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
22 authors.
Richard J HuntsmanDivision of Pediatric Neurology (Huntsman), Department of Pediatrics, and Cannabinoid Research Initiative of Saskatchewan (Huntsman, Alcorn, Szafron, Shackelford), University of Saskatchewan, Saskatoon, Sask.; Canadian Childhood Cannabinoid Clinical Trial (C4T) Consortium (Kelly, Crooks, Finkelstein, Gilpin, Oberlander, Rassekh, Repetski, Rieder, Vaillancourt); George and Fay Yee Centre for Health Care Innovation (Kelly), Children's Hospital Research Institute of Manitoba, Department of Pediatrics & Child Health, University of Manitoba, Winnipeg, Man.; College of Pharmacy and Nutrition (Alcorn), University of Saskatchewan, Saskatoon, Sask.; Division of Pediatric Neurology (Appendino, Jacobs), Department of Pediatrics, and Alberta Children's Hospital Research Institute (Appendino, Jacobs), University of Calgary, Calgary, Alta.; Départment de pédiatrie (Bélanger), Faculté de médecine, Université Laval, Québec, Que.; Canadian Paediatric Society (Bélanger, Moore-Hepburn, 't Jong), Ottawa, Ont.; Division of Paediatric Haematology/Oncology (Crooks), Department of Pediatrics, Dalhousie University, Halifax, NS; Divisions of Emergency Medicine and Clinical Pharmacology and Toxicology (Finkelstein), Department of Pediatrics, University of Toronto, Toronto, Ont.; The Rosalind and Morris Goodman Family Pediatric Formulations Centre of the Sainte-Justine University Hospital Centre (Gilpin, Litalien), Montréal, Que.; Neurology Centre of Toronto (Lewis); Division of Pediatric Neurology (Lewis), Department of Pediatrics, University of Toronto, Toronto, Ont.; Départment de pédiatrie (Litalien), Faculté de médecine, Université de Montréal, Montréal, Que.; Division of Paediatric Medicine (Moore-Hepburn), Department of Paediatrics, University of Toronto, Toronto, Ont.; Department of Pediatrics and School of Population and Public Health (Oberlander), and Division of Pediatric Hematology/Oncology/BMT (Rassekh), Department of Pediatrics, University of British Columbia, Vancouver, BC; Division of Pediatric Pharmacology (Rieder), Department of Pediatrics, University of Western Ontario, London, Ont.; Amarimed of Colorado (Shackelford), Denver, Colorado; Division of Palliative Care (Siden), Department of Pediatrics, University of British Columbia; Canuck Place (Siden), Children's Hospice, Vancouver, BC; School of Public Health (Szafron), University of Saskatchewan, Saskatoon, Sask.; Departments of Pediatrics and Pharmacology ('t Jong), Max Rady College of Medicine, University of Manitoba, Winnipeg, Man.; Children's Hospital of Eastern Ontario (Vaillancourt), Ottawa, Ont. dr.huntsman@usask.ca.
Lauren E KellyDivision of Pediatric Neurology (Huntsman), Department of Pediatrics, and Cannabinoid Research Initiative of Saskatchewan (Huntsman, Alcorn, Szafron, Shackelford), University of Saskatchewan, Saskatoon, Sask.; Canadian Childhood Cannabinoid Clinical Trial (C4T) Consortium (Kelly, Crooks, Finkelstein, Gilpin, Oberlander, Rassekh, Repetski, Rieder, Vaillancourt); George and Fay Yee Centre for Health Care Innovation (Kelly), Children's Hospital Research Institute of Manitoba, Department of Pediatrics & Child Health, University of Manitoba, Winnipeg, Man.; College of Pharmacy and Nutrition (Alcorn), University of Saskatchewan, Saskatoon, Sask.; Division of Pediatric Neurology (Appendino, Jacobs), Department of Pediatrics, and Alberta Children's Hospital Research Institute (Appendino, Jacobs), University of Calgary, Calgary, Alta.; Départment de pédiatrie (Bélanger), Faculté de médecine, Université Laval, Québec, Que.; Canadian Paediatric Society (Bélanger, Moore-Hepburn, 't Jong), Ottawa, Ont.; Division of Paediatric Haematology/Oncology (Crooks), Department of Pediatrics, Dalhousie University, Halifax, NS; Divisions of Emergency Medicine and Clinical Pharmacology and Toxicology (Finkelstein), Department of Pediatrics, University of Toronto, Toronto, Ont.; The Rosalind and Morris Goodman Family Pediatric Formulations Centre of the Sainte-Justine University Hospital Centre (Gilpin, Litalien), Montréal, Que.; Neurology Centre of Toronto (Lewis); Division of Pediatric Neurology (Lewis), Department of Pediatrics, University of Toronto, Toronto, Ont.; Départment de pédiatrie (Litalien), Faculté de médecine, Université de Montréal, Montréal, Que.; Division of Paediatric Medicine (Moore-Hepburn), Department of Paediatrics, University of Toronto, Toronto, Ont.; Department of Pediatrics and School of Population and Public Health (Oberlander), and Division of Pediatric Hematology/Oncology/BMT (Rassekh), Department of Pediatrics, University of British Columbia, Vancouver, BC; Division of Pediatric Pharmacology (Rieder), Department of Pediatrics, University of Western Ontario, London, Ont.; Amarimed of Colorado (Shackelford), Denver, Colorado; Division of Palliative Care (Siden), Department of Pediatrics, University of British Columbia; Canuck Place (Siden), Children's Hospice, Vancouver, BC; School of Public Health (Szafron), University of Saskatchewan, Saskatoon, Sask.; Departments of Pediatrics and Pharmacology ('t Jong), Max Rady College of Medicine, University of Manitoba, Winnipeg, Man.; Children's Hospital of Eastern Ontario (Vaillancourt), Ottawa, Ont.
Jane AlcornDivision of Pediatric Neurology (Huntsman), Department of Pediatrics, and Cannabinoid Research Initiative of Saskatchewan (Huntsman, Alcorn, Szafron, Shackelford), University of Saskatchewan, Saskatoon, Sask.; Canadian Childhood Cannabinoid Clinical Trial (C4T) Consortium (Kelly, Crooks, Finkelstein, Gilpin, Oberlander, Rassekh, Repetski, Rieder, Vaillancourt); George and Fay Yee Centre for Health Care Innovation (Kelly), Children's Hospital Research Institute of Manitoba, Department of Pediatrics & Child Health, University of Manitoba, Winnipeg, Man.; College of Pharmacy and Nutrition (Alcorn), University of Saskatchewan, Saskatoon, Sask.; Division of Pediatric Neurology (Appendino, Jacobs), Department of Pediatrics, and Alberta Children's Hospital Research Institute (Appendino, Jacobs), University of Calgary, Calgary, Alta.; Départment de pédiatrie (Bélanger), Faculté de médecine, Université Laval, Québec, Que.; Canadian Paediatric Society (Bélanger, Moore-Hepburn, 't Jong), Ottawa, Ont.; Division of Paediatric Haematology/Oncology (Crooks), Department of Pediatrics, Dalhousie University, Halifax, NS; Divisions of Emergency Medicine and Clinical Pharmacology and Toxicology (Finkelstein), Department of Pediatrics, University of Toronto, Toronto, Ont.; The Rosalind and Morris Goodman Family Pediatric Formulations Centre of the Sainte-Justine University Hospital Centre (Gilpin, Litalien), Montréal, Que.; Neurology Centre of Toronto (Lewis); Division of Pediatric Neurology (Lewis), Department of Pediatrics, University of Toronto, Toronto, Ont.; Départment de pédiatrie (Litalien), Faculté de médecine, Université de Montréal, Montréal, Que.; Division of Paediatric Medicine (Moore-Hepburn), Department of Paediatrics, University of Toronto, Toronto, Ont.; Department of Pediatrics and School of Population and Public Health (Oberlander), and Division of Pediatric Hematology/Oncology/BMT (Rassekh), Department of Pediatrics, University of British Columbia, Vancouver, BC; Division of Pediatric Pharmacology (Rieder), Department of Pediatrics, University of Western Ontario, London, Ont.; Amarimed of Colorado (Shackelford), Denver, Colorado; Division of Palliative Care (Siden), Department of Pediatrics, University of British Columbia; Canuck Place (Siden), Children's Hospice, Vancouver, BC; School of Public Health (Szafron), University of Saskatchewan, Saskatoon, Sask.; Departments of Pediatrics and Pharmacology ('t Jong), Max Rady College of Medicine, University of Manitoba, Winnipeg, Man.; Children's Hospital of Eastern Ontario (Vaillancourt), Ottawa, Ont.
Juan Pablo AppendinoDivision of Pediatric Neurology (Huntsman), Department of Pediatrics, and Cannabinoid Research Initiative of Saskatchewan (Huntsman, Alcorn, Szafron, Shackelford), University of Saskatchewan, Saskatoon, Sask.; Canadian Childhood Cannabinoid Clinical Trial (C4T) Consortium (Kelly, Crooks, Finkelstein, Gilpin, Oberlander, Rassekh, Repetski, Rieder, Vaillancourt); George and Fay Yee Centre for Health Care Innovation (Kelly), Children's Hospital Research Institute of Manitoba, Department of Pediatrics & Child Health, University of Manitoba, Winnipeg, Man.; College of Pharmacy and Nutrition (Alcorn), University of Saskatchewan, Saskatoon, Sask.; Division of Pediatric Neurology (Appendino, Jacobs), Department of Pediatrics, and Alberta Children's Hospital Research Institute (Appendino, Jacobs), University of Calgary, Calgary, Alta.; Départment de pédiatrie (Bélanger), Faculté de médecine, Université Laval, Québec, Que.; Canadian Paediatric Society (Bélanger, Moore-Hepburn, 't Jong), Ottawa, Ont.; Division of Paediatric Haematology/Oncology (Crooks), Department of Pediatrics, Dalhousie University, Halifax, NS; Divisions of Emergency Medicine and Clinical Pharmacology and Toxicology (Finkelstein), Department of Pediatrics, University of Toronto, Toronto, Ont.; The Rosalind and Morris Goodman Family Pediatric Formulations Centre of the Sainte-Justine University Hospital Centre (Gilpin, Litalien), Montréal, Que.; Neurology Centre of Toronto (Lewis); Division of Pediatric Neurology (Lewis), Department of Pediatrics, University of Toronto, Toronto, Ont.; Départment de pédiatrie (Litalien), Faculté de médecine, Université de Montréal, Montréal, Que.; Division of Paediatric Medicine (Moore-Hepburn), Department of Paediatrics, University of Toronto, Toronto, Ont.; Department of Pediatrics and School of Population and Public Health (Oberlander), and Division of Pediatric Hematology/Oncology/BMT (Rassekh), Department of Pediatrics, University of British Columbia, Vancouver, BC; Division of Pediatric Pharmacology (Rieder), Department of Pediatrics, University of Western Ontario, London, Ont.; Amarimed of Colorado (Shackelford), Denver, Colorado; Division of Palliative Care (Siden), Department of Pediatrics, University of British Columbia; Canuck Place (Siden), Children's Hospice, Vancouver, BC; School of Public Health (Szafron), University of Saskatchewan, Saskatoon, Sask.; Departments of Pediatrics and Pharmacology ('t Jong), Max Rady College of Medicine, University of Manitoba, Winnipeg, Man.; Children's Hospital of Eastern Ontario (Vaillancourt), Ottawa, Ont.
Richard E BélangerDivision of Pediatric Neurology (Huntsman), Department of Pediatrics, and Cannabinoid Research Initiative of Saskatchewan (Huntsman, Alcorn, Szafron, Shackelford), University of Saskatchewan, Saskatoon, Sask.; Canadian Childhood Cannabinoid Clinical Trial (C4T) Consortium (Kelly, Crooks, Finkelstein, Gilpin, Oberlander, Rassekh, Repetski, Rieder, Vaillancourt); George and Fay Yee Centre for Health Care Innovation (Kelly), Children's Hospital Research Institute of Manitoba, Department of Pediatrics & Child Health, University of Manitoba, Winnipeg, Man.; College of Pharmacy and Nutrition (Alcorn), University of Saskatchewan, Saskatoon, Sask.; Division of Pediatric Neurology (Appendino, Jacobs), Department of Pediatrics, and Alberta Children's Hospital Research Institute (Appendino, Jacobs), University of Calgary, Calgary, Alta.; Départment de pédiatrie (Bélanger), Faculté de médecine, Université Laval, Québec, Que.; Canadian Paediatric Society (Bélanger, Moore-Hepburn, 't Jong), Ottawa, Ont.; Division of Paediatric Haematology/Oncology (Crooks), Department of Pediatrics, Dalhousie University, Halifax, NS; Divisions of Emergency Medicine and Clinical Pharmacology and Toxicology (Finkelstein), Department of Pediatrics, University of Toronto, Toronto, Ont.; The Rosalind and Morris Goodman Family Pediatric Formulations Centre of the Sainte-Justine University Hospital Centre (Gilpin, Litalien), Montréal, Que.; Neurology Centre of Toronto (Lewis); Division of Pediatric Neurology (Lewis), Department of Pediatrics, University of Toronto, Toronto, Ont.; Départment de pédiatrie (Litalien), Faculté de médecine, Université de Montréal, Montréal, Que.; Division of Paediatric Medicine (Moore-Hepburn), Department of Paediatrics, University of Toronto, Toronto, Ont.; Department of Pediatrics and School of Population and Public Health (Oberlander), and Division of Pediatric Hematology/Oncology/BMT (Rassekh), Department of Pediatrics, University of British Columbia, Vancouver, BC; Division of Pediatric Pharmacology (Rieder), Department of Pediatrics, University of Western Ontario, London, Ont.; Amarimed of Colorado (Shackelford), Denver, Colorado; Division of Palliative Care (Siden), Department of Pediatrics, University of British Columbia; Canuck Place (Siden), Children's Hospice, Vancouver, BC; School of Public Health (Szafron), University of Saskatchewan, Saskatoon, Sask.; Departments of Pediatrics and Pharmacology ('t Jong), Max Rady College of Medicine, University of Manitoba, Winnipeg, Man.; Children's Hospital of Eastern Ontario (Vaillancourt), Ottawa, Ont.
Bruce CrooksDivision of Pediatric Neurology (Huntsman), Department of Pediatrics, and Cannabinoid Research Initiative of Saskatchewan (Huntsman, Alcorn, Szafron, Shackelford), University of Saskatchewan, Saskatoon, Sask.; Canadian Childhood Cannabinoid Clinical Trial (C4T) Consortium (Kelly, Crooks, Finkelstein, Gilpin, Oberlander, Rassekh, Repetski, Rieder, Vaillancourt); George and Fay Yee Centre for Health Care Innovation (Kelly), Children's Hospital Research Institute of Manitoba, Department of Pediatrics & Child Health, University of Manitoba, Winnipeg, Man.; College of Pharmacy and Nutrition (Alcorn), University of Saskatchewan, Saskatoon, Sask.; Division of Pediatric Neurology (Appendino, Jacobs), Department of Pediatrics, and Alberta Children's Hospital Research Institute (Appendino, Jacobs), University of Calgary, Calgary, Alta.; Départment de pédiatrie (Bélanger), Faculté de médecine, Université Laval, Québec, Que.; Canadian Paediatric Society (Bélanger, Moore-Hepburn, 't Jong), Ottawa, Ont.; Division of Paediatric Haematology/Oncology (Crooks), Department of Pediatrics, Dalhousie University, Halifax, NS; Divisions of Emergency Medicine and Clinical Pharmacology and Toxicology (Finkelstein), Department of Pediatrics, University of Toronto, Toronto, Ont.; The Rosalind and Morris Goodman Family Pediatric Formulations Centre of the Sainte-Justine University Hospital Centre (Gilpin, Litalien), Montréal, Que.; Neurology Centre of Toronto (Lewis); Division of Pediatric Neurology (Lewis), Department of Pediatrics, University of Toronto, Toronto, Ont.; Départment de pédiatrie (Litalien), Faculté de médecine, Université de Montréal, Montréal, Que.; Division of Paediatric Medicine (Moore-Hepburn), Department of Paediatrics, University of Toronto, Toronto, Ont.; Department of Pediatrics and School of Population and Public Health (Oberlander), and Division of Pediatric Hematology/Oncology/BMT (Rassekh), Department of Pediatrics, University of British Columbia, Vancouver, BC; Division of Pediatric Pharmacology (Rieder), Department of Pediatrics, University of Western Ontario, London, Ont.; Amarimed of Colorado (Shackelford), Denver, Colorado; Division of Palliative Care (Siden), Department of Pediatrics, University of British Columbia; Canuck Place (Siden), Children's Hospice, Vancouver, BC; School of Public Health (Szafron), University of Saskatchewan, Saskatoon, Sask.; Departments of Pediatrics and Pharmacology ('t Jong), Max Rady College of Medicine, University of Manitoba, Winnipeg, Man.; Children's Hospital of Eastern Ontario (Vaillancourt), Ottawa, Ont.
Yaron FinkelsteinDivision of Pediatric Neurology (Huntsman), Department of Pediatrics, and Cannabinoid Research Initiative of Saskatchewan (Huntsman, Alcorn, Szafron, Shackelford), University of Saskatchewan, Saskatoon, Sask.; Canadian Childhood Cannabinoid Clinical Trial (C4T) Consortium (Kelly, Crooks, Finkelstein, Gilpin, Oberlander, Rassekh, Repetski, Rieder, Vaillancourt); George and Fay Yee Centre for Health Care Innovation (Kelly), Children's Hospital Research Institute of Manitoba, Department of Pediatrics & Child Health, University of Manitoba, Winnipeg, Man.; College of Pharmacy and Nutrition (Alcorn), University of Saskatchewan, Saskatoon, Sask.; Division of Pediatric Neurology (Appendino, Jacobs), Department of Pediatrics, and Alberta Children's Hospital Research Institute (Appendino, Jacobs), University of Calgary, Calgary, Alta.; Départment de pédiatrie (Bélanger), Faculté de médecine, Université Laval, Québec, Que.; Canadian Paediatric Society (Bélanger, Moore-Hepburn, 't Jong), Ottawa, Ont.; Division of Paediatric Haematology/Oncology (Crooks), Department of Pediatrics, Dalhousie University, Halifax, NS; Divisions of Emergency Medicine and Clinical Pharmacology and Toxicology (Finkelstein), Department of Pediatrics, University of Toronto, Toronto, Ont.; The Rosalind and Morris Goodman Family Pediatric Formulations Centre of the Sainte-Justine University Hospital Centre (Gilpin, Litalien), Montréal, Que.; Neurology Centre of Toronto (Lewis); Division of Pediatric Neurology (Lewis), Department of Pediatrics, University of Toronto, Toronto, Ont.; Départment de pédiatrie (Litalien), Faculté de médecine, Université de Montréal, Montréal, Que.; Division of Paediatric Medicine (Moore-Hepburn), Department of Paediatrics, University of Toronto, Toronto, Ont.; Department of Pediatrics and School of Population and Public Health (Oberlander), and Division of Pediatric Hematology/Oncology/BMT (Rassekh), Department of Pediatrics, University of British Columbia, Vancouver, BC; Division of Pediatric Pharmacology (Rieder), Department of Pediatrics, University of Western Ontario, London, Ont.; Amarimed of Colorado (Shackelford), Denver, Colorado; Division of Palliative Care (Siden), Department of Pediatrics, University of British Columbia; Canuck Place (Siden), Children's Hospice, Vancouver, BC; School of Public Health (Szafron), University of Saskatchewan, Saskatoon, Sask.; Departments of Pediatrics and Pharmacology ('t Jong), Max Rady College of Medicine, University of Manitoba, Winnipeg, Man.; Children's Hospital of Eastern Ontario (Vaillancourt), Ottawa, Ont.
Andrea GilpinDivision of Pediatric Neurology (Huntsman), Department of Pediatrics, and Cannabinoid Research Initiative of Saskatchewan (Huntsman, Alcorn, Szafron, Shackelford), University of Saskatchewan, Saskatoon, Sask.; Canadian Childhood Cannabinoid Clinical Trial (C4T) Consortium (Kelly, Crooks, Finkelstein, Gilpin, Oberlander, Rassekh, Repetski, Rieder, Vaillancourt); George and Fay Yee Centre for Health Care Innovation (Kelly), Children's Hospital Research Institute of Manitoba, Department of Pediatrics & Child Health, University of Manitoba, Winnipeg, Man.; College of Pharmacy and Nutrition (Alcorn), University of Saskatchewan, Saskatoon, Sask.; Division of Pediatric Neurology (Appendino, Jacobs), Department of Pediatrics, and Alberta Children's Hospital Research Institute (Appendino, Jacobs), University of Calgary, Calgary, Alta.; Départment de pédiatrie (Bélanger), Faculté de médecine, Université Laval, Québec, Que.; Canadian Paediatric Society (Bélanger, Moore-Hepburn, 't Jong), Ottawa, Ont.; Division of Paediatric Haematology/Oncology (Crooks), Department of Pediatrics, Dalhousie University, Halifax, NS; Divisions of Emergency Medicine and Clinical Pharmacology and Toxicology (Finkelstein), Department of Pediatrics, University of Toronto, Toronto, Ont.; The Rosalind and Morris Goodman Family Pediatric Formulations Centre of the Sainte-Justine University Hospital Centre (Gilpin, Litalien), Montréal, Que.; Neurology Centre of Toronto (Lewis); Division of Pediatric Neurology (Lewis), Department of Pediatrics, University of Toronto, Toronto, Ont.; Départment de pédiatrie (Litalien), Faculté de médecine, Université de Montréal, Montréal, Que.; Division of Paediatric Medicine (Moore-Hepburn), Department of Paediatrics, University of Toronto, Toronto, Ont.; Department of Pediatrics and School of Population and Public Health (Oberlander), and Division of Pediatric Hematology/Oncology/BMT (Rassekh), Department of Pediatrics, University of British Columbia, Vancouver, BC; Division of Pediatric Pharmacology (Rieder), Department of Pediatrics, University of Western Ontario, London, Ont.; Amarimed of Colorado (Shackelford), Denver, Colorado; Division of Palliative Care (Siden), Department of Pediatrics, University of British Columbia; Canuck Place (Siden), Children's Hospice, Vancouver, BC; School of Public Health (Szafron), University of Saskatchewan, Saskatoon, Sask.; Departments of Pediatrics and Pharmacology ('t Jong), Max Rady College of Medicine, University of Manitoba, Winnipeg, Man.; Children's Hospital of Eastern Ontario (Vaillancourt), Ottawa, Ont.
Evan LewisDivision of Pediatric Neurology (Huntsman), Department of Pediatrics, and Cannabinoid Research Initiative of Saskatchewan (Huntsman, Alcorn, Szafron, Shackelford), University of Saskatchewan, Saskatoon, Sask.; Canadian Childhood Cannabinoid Clinical Trial (C4T) Consortium (Kelly, Crooks, Finkelstein, Gilpin, Oberlander, Rassekh, Repetski, Rieder, Vaillancourt); George and Fay Yee Centre for Health Care Innovation (Kelly), Children's Hospital Research Institute of Manitoba, Department of Pediatrics & Child Health, University of Manitoba, Winnipeg, Man.; College of Pharmacy and Nutrition (Alcorn), University of Saskatchewan, Saskatoon, Sask.; Division of Pediatric Neurology (Appendino, Jacobs), Department of Pediatrics, and Alberta Children's Hospital Research Institute (Appendino, Jacobs), University of Calgary, Calgary, Alta.; Départment de pédiatrie (Bélanger), Faculté de médecine, Université Laval, Québec, Que.; Canadian Paediatric Society (Bélanger, Moore-Hepburn, 't Jong), Ottawa, Ont.; Division of Paediatric Haematology/Oncology (Crooks), Department of Pediatrics, Dalhousie University, Halifax, NS; Divisions of Emergency Medicine and Clinical Pharmacology and Toxicology (Finkelstein), Department of Pediatrics, University of Toronto, Toronto, Ont.; The Rosalind and Morris Goodman Family Pediatric Formulations Centre of the Sainte-Justine University Hospital Centre (Gilpin, Litalien), Montréal, Que.; Neurology Centre of Toronto (Lewis); Division of Pediatric Neurology (Lewis), Department of Pediatrics, University of Toronto, Toronto, Ont.; Départment de pédiatrie (Litalien), Faculté de médecine, Université de Montréal, Montréal, Que.; Division of Paediatric Medicine (Moore-Hepburn), Department of Paediatrics, University of Toronto, Toronto, Ont.; Department of Pediatrics and School of Population and Public Health (Oberlander), and Division of Pediatric Hematology/Oncology/BMT (Rassekh), Department of Pediatrics, University of British Columbia, Vancouver, BC; Division of Pediatric Pharmacology (Rieder), Department of Pediatrics, University of Western Ontario, London, Ont.; Amarimed of Colorado (Shackelford), Denver, Colorado; Division of Palliative Care (Siden), Department of Pediatrics, University of British Columbia; Canuck Place (Siden), Children's Hospice, Vancouver, BC; School of Public Health (Szafron), University of Saskatchewan, Saskatoon, Sask.; Departments of Pediatrics and Pharmacology ('t Jong), Max Rady College of Medicine, University of Manitoba, Winnipeg, Man.; Children's Hospital of Eastern Ontario (Vaillancourt), Ottawa, Ont.
Catherine LitalienDivision of Pediatric Neurology (Huntsman), Department of Pediatrics, and Cannabinoid Research Initiative of Saskatchewan (Huntsman, Alcorn, Szafron, Shackelford), University of Saskatchewan, Saskatoon, Sask.; Canadian Childhood Cannabinoid Clinical Trial (C4T) Consortium (Kelly, Crooks, Finkelstein, Gilpin, Oberlander, Rassekh, Repetski, Rieder, Vaillancourt); George and Fay Yee Centre for Health Care Innovation (Kelly), Children's Hospital Research Institute of Manitoba, Department of Pediatrics & Child Health, University of Manitoba, Winnipeg, Man.; College of Pharmacy and Nutrition (Alcorn), University of Saskatchewan, Saskatoon, Sask.; Division of Pediatric Neurology (Appendino, Jacobs), Department of Pediatrics, and Alberta Children's Hospital Research Institute (Appendino, Jacobs), University of Calgary, Calgary, Alta.; Départment de pédiatrie (Bélanger), Faculté de médecine, Université Laval, Québec, Que.; Canadian Paediatric Society (Bélanger, Moore-Hepburn, 't Jong), Ottawa, Ont.; Division of Paediatric Haematology/Oncology (Crooks), Department of Pediatrics, Dalhousie University, Halifax, NS; Divisions of Emergency Medicine and Clinical Pharmacology and Toxicology (Finkelstein), Department of Pediatrics, University of Toronto, Toronto, Ont.; The Rosalind and Morris Goodman Family Pediatric Formulations Centre of the Sainte-Justine University Hospital Centre (Gilpin, Litalien), Montréal, Que.; Neurology Centre of Toronto (Lewis); Division of Pediatric Neurology (Lewis), Department of Pediatrics, University of Toronto, Toronto, Ont.; Départment de pédiatrie (Litalien), Faculté de médecine, Université de Montréal, Montréal, Que.; Division of Paediatric Medicine (Moore-Hepburn), Department of Paediatrics, University of Toronto, Toronto, Ont.; Department of Pediatrics and School of Population and Public Health (Oberlander), and Division of Pediatric Hematology/Oncology/BMT (Rassekh), Department of Pediatrics, University of British Columbia, Vancouver, BC; Division of Pediatric Pharmacology (Rieder), Department of Pediatrics, University of Western Ontario, London, Ont.; Amarimed of Colorado (Shackelford), Denver, Colorado; Division of Palliative Care (Siden), Department of Pediatrics, University of British Columbia; Canuck Place (Siden), Children's Hospice, Vancouver, BC; School of Public Health (Szafron), University of Saskatchewan, Saskatoon, Sask.; Departments of Pediatrics and Pharmacology ('t Jong), Max Rady College of Medicine, University of Manitoba, Winnipeg, Man.; Children's Hospital of Eastern Ontario (Vaillancourt), Ottawa, Ont.
Julia JacobsDivision of Pediatric Neurology (Huntsman), Department of Pediatrics, and Cannabinoid Research Initiative of Saskatchewan (Huntsman, Alcorn, Szafron, Shackelford), University of Saskatchewan, Saskatoon, Sask.; Canadian Childhood Cannabinoid Clinical Trial (C4T) Consortium (Kelly, Crooks, Finkelstein, Gilpin, Oberlander, Rassekh, Repetski, Rieder, Vaillancourt); George and Fay Yee Centre for Health Care Innovation (Kelly), Children's Hospital Research Institute of Manitoba, Department of Pediatrics & Child Health, University of Manitoba, Winnipeg, Man.; College of Pharmacy and Nutrition (Alcorn), University of Saskatchewan, Saskatoon, Sask.; Division of Pediatric Neurology (Appendino, Jacobs), Department of Pediatrics, and Alberta Children's Hospital Research Institute (Appendino, Jacobs), University of Calgary, Calgary, Alta.; Départment de pédiatrie (Bélanger), Faculté de médecine, Université Laval, Québec, Que.; Canadian Paediatric Society (Bélanger, Moore-Hepburn, 't Jong), Ottawa, Ont.; Division of Paediatric Haematology/Oncology (Crooks), Department of Pediatrics, Dalhousie University, Halifax, NS; Divisions of Emergency Medicine and Clinical Pharmacology and Toxicology (Finkelstein), Department of Pediatrics, University of Toronto, Toronto, Ont.; The Rosalind and Morris Goodman Family Pediatric Formulations Centre of the Sainte-Justine University Hospital Centre (Gilpin, Litalien), Montréal, Que.; Neurology Centre of Toronto (Lewis); Division of Pediatric Neurology (Lewis), Department of Pediatrics, University of Toronto, Toronto, Ont.; Départment de pédiatrie (Litalien), Faculté de médecine, Université de Montréal, Montréal, Que.; Division of Paediatric Medicine (Moore-Hepburn), Department of Paediatrics, University of Toronto, Toronto, Ont.; Department of Pediatrics and School of Population and Public Health (Oberlander), and Division of Pediatric Hematology/Oncology/BMT (Rassekh), Department of Pediatrics, University of British Columbia, Vancouver, BC; Division of Pediatric Pharmacology (Rieder), Department of Pediatrics, University of Western Ontario, London, Ont.; Amarimed of Colorado (Shackelford), Denver, Colorado; Division of Palliative Care (Siden), Department of Pediatrics, University of British Columbia; Canuck Place (Siden), Children's Hospice, Vancouver, BC; School of Public Health (Szafron), University of Saskatchewan, Saskatoon, Sask.; Departments of Pediatrics and Pharmacology ('t Jong), Max Rady College of Medicine, University of Manitoba, Winnipeg, Man.; Children's Hospital of Eastern Ontario (Vaillancourt), Ottawa, Ont.
Charlotte Moore-HepburnDivision of Pediatric Neurology (Huntsman), Department of Pediatrics, and Cannabinoid Research Initiative of Saskatchewan (Huntsman, Alcorn, Szafron, Shackelford), University of Saskatchewan, Saskatoon, Sask.; Canadian Childhood Cannabinoid Clinical Trial (C4T) Consortium (Kelly, Crooks, Finkelstein, Gilpin, Oberlander, Rassekh, Repetski, Rieder, Vaillancourt); George and Fay Yee Centre for Health Care Innovation (Kelly), Children's Hospital Research Institute of Manitoba, Department of Pediatrics & Child Health, University of Manitoba, Winnipeg, Man.; College of Pharmacy and Nutrition (Alcorn), University of Saskatchewan, Saskatoon, Sask.; Division of Pediatric Neurology (Appendino, Jacobs), Department of Pediatrics, and Alberta Children's Hospital Research Institute (Appendino, Jacobs), University of Calgary, Calgary, Alta.; Départment de pédiatrie (Bélanger), Faculté de médecine, Université Laval, Québec, Que.; Canadian Paediatric Society (Bélanger, Moore-Hepburn, 't Jong), Ottawa, Ont.; Division of Paediatric Haematology/Oncology (Crooks), Department of Pediatrics, Dalhousie University, Halifax, NS; Divisions of Emergency Medicine and Clinical Pharmacology and Toxicology (Finkelstein), Department of Pediatrics, University of Toronto, Toronto, Ont.; The Rosalind and Morris Goodman Family Pediatric Formulations Centre of the Sainte-Justine University Hospital Centre (Gilpin, Litalien), Montréal, Que.; Neurology Centre of Toronto (Lewis); Division of Pediatric Neurology (Lewis), Department of Pediatrics, University of Toronto, Toronto, Ont.; Départment de pédiatrie (Litalien), Faculté de médecine, Université de Montréal, Montréal, Que.; Division of Paediatric Medicine (Moore-Hepburn), Department of Paediatrics, University of Toronto, Toronto, Ont.; Department of Pediatrics and School of Population and Public Health (Oberlander), and Division of Pediatric Hematology/Oncology/BMT (Rassekh), Department of Pediatrics, University of British Columbia, Vancouver, BC; Division of Pediatric Pharmacology (Rieder), Department of Pediatrics, University of Western Ontario, London, Ont.; Amarimed of Colorado (Shackelford), Denver, Colorado; Division of Palliative Care (Siden), Department of Pediatrics, University of British Columbia; Canuck Place (Siden), Children's Hospice, Vancouver, BC; School of Public Health (Szafron), University of Saskatchewan, Saskatoon, Sask.; Departments of Pediatrics and Pharmacology ('t Jong), Max Rady College of Medicine, University of Manitoba, Winnipeg, Man.; Children's Hospital of Eastern Ontario (Vaillancourt), Ottawa, Ont.
Timothy OberlanderDivision of Pediatric Neurology (Huntsman), Department of Pediatrics, and Cannabinoid Research Initiative of Saskatchewan (Huntsman, Alcorn, Szafron, Shackelford), University of Saskatchewan, Saskatoon, Sask.; Canadian Childhood Cannabinoid Clinical Trial (C4T) Consortium (Kelly, Crooks, Finkelstein, Gilpin, Oberlander, Rassekh, Repetski, Rieder, Vaillancourt); George and Fay Yee Centre for Health Care Innovation (Kelly), Children's Hospital Research Institute of Manitoba, Department of Pediatrics & Child Health, University of Manitoba, Winnipeg, Man.; College of Pharmacy and Nutrition (Alcorn), University of Saskatchewan, Saskatoon, Sask.; Division of Pediatric Neurology (Appendino, Jacobs), Department of Pediatrics, and Alberta Children's Hospital Research Institute (Appendino, Jacobs), University of Calgary, Calgary, Alta.; Départment de pédiatrie (Bélanger), Faculté de médecine, Université Laval, Québec, Que.; Canadian Paediatric Society (Bélanger, Moore-Hepburn, 't Jong), Ottawa, Ont.; Division of Paediatric Haematology/Oncology (Crooks), Department of Pediatrics, Dalhousie University, Halifax, NS; Divisions of Emergency Medicine and Clinical Pharmacology and Toxicology (Finkelstein), Department of Pediatrics, University of Toronto, Toronto, Ont.; The Rosalind and Morris Goodman Family Pediatric Formulations Centre of the Sainte-Justine University Hospital Centre (Gilpin, Litalien), Montréal, Que.; Neurology Centre of Toronto (Lewis); Division of Pediatric Neurology (Lewis), Department of Pediatrics, University of Toronto, Toronto, Ont.; Départment de pédiatrie (Litalien), Faculté de médecine, Université de Montréal, Montréal, Que.; Division of Paediatric Medicine (Moore-Hepburn), Department of Paediatrics, University of Toronto, Toronto, Ont.; Department of Pediatrics and School of Population and Public Health (Oberlander), and Division of Pediatric Hematology/Oncology/BMT (Rassekh), Department of Pediatrics, University of British Columbia, Vancouver, BC; Division of Pediatric Pharmacology (Rieder), Department of Pediatrics, University of Western Ontario, London, Ont.; Amarimed of Colorado (Shackelford), Denver, Colorado; Division of Palliative Care (Siden), Department of Pediatrics, University of British Columbia; Canuck Place (Siden), Children's Hospice, Vancouver, BC; School of Public Health (Szafron), University of Saskatchewan, Saskatoon, Sask.; Departments of Pediatrics and Pharmacology ('t Jong), Max Rady College of Medicine, University of Manitoba, Winnipeg, Man.; Children's Hospital of Eastern Ontario (Vaillancourt), Ottawa, Ont.
S Rod RassekhDivision of Pediatric Neurology (Huntsman), Department of Pediatrics, and Cannabinoid Research Initiative of Saskatchewan (Huntsman, Alcorn, Szafron, Shackelford), University of Saskatchewan, Saskatoon, Sask.; Canadian Childhood Cannabinoid Clinical Trial (C4T) Consortium (Kelly, Crooks, Finkelstein, Gilpin, Oberlander, Rassekh, Repetski, Rieder, Vaillancourt); George and Fay Yee Centre for Health Care Innovation (Kelly), Children's Hospital Research Institute of Manitoba, Department of Pediatrics & Child Health, University of Manitoba, Winnipeg, Man.; College of Pharmacy and Nutrition (Alcorn), University of Saskatchewan, Saskatoon, Sask.; Division of Pediatric Neurology (Appendino, Jacobs), Department of Pediatrics, and Alberta Children's Hospital Research Institute (Appendino, Jacobs), University of Calgary, Calgary, Alta.; Départment de pédiatrie (Bélanger), Faculté de médecine, Université Laval, Québec, Que.; Canadian Paediatric Society (Bélanger, Moore-Hepburn, 't Jong), Ottawa, Ont.; Division of Paediatric Haematology/Oncology (Crooks), Department of Pediatrics, Dalhousie University, Halifax, NS; Divisions of Emergency Medicine and Clinical Pharmacology and Toxicology (Finkelstein), Department of Pediatrics, University of Toronto, Toronto, Ont.; The Rosalind and Morris Goodman Family Pediatric Formulations Centre of the Sainte-Justine University Hospital Centre (Gilpin, Litalien), Montréal, Que.; Neurology Centre of Toronto (Lewis); Division of Pediatric Neurology (Lewis), Department of Pediatrics, University of Toronto, Toronto, Ont.; Départment de pédiatrie (Litalien), Faculté de médecine, Université de Montréal, Montréal, Que.; Division of Paediatric Medicine (Moore-Hepburn), Department of Paediatrics, University of Toronto, Toronto, Ont.; Department of Pediatrics and School of Population and Public Health (Oberlander), and Division of Pediatric Hematology/Oncology/BMT (Rassekh), Department of Pediatrics, University of British Columbia, Vancouver, BC; Division of Pediatric Pharmacology (Rieder), Department of Pediatrics, University of Western Ontario, London, Ont.; Amarimed of Colorado (Shackelford), Denver, Colorado; Division of Palliative Care (Siden), Department of Pediatrics, University of British Columbia; Canuck Place (Siden), Children's Hospice, Vancouver, BC; School of Public Health (Szafron), University of Saskatchewan, Saskatoon, Sask.; Departments of Pediatrics and Pharmacology ('t Jong), Max Rady College of Medicine, University of Manitoba, Winnipeg, Man.; Children's Hospital of Eastern Ontario (Vaillancourt), Ottawa, Ont.
Alexander E RepetskiDivision of Pediatric Neurology (Huntsman), Department of Pediatrics, and Cannabinoid Research Initiative of Saskatchewan (Huntsman, Alcorn, Szafron, Shackelford), University of Saskatchewan, Saskatoon, Sask.; Canadian Childhood Cannabinoid Clinical Trial (C4T) Consortium (Kelly, Crooks, Finkelstein, Gilpin, Oberlander, Rassekh, Repetski, Rieder, Vaillancourt); George and Fay Yee Centre for Health Care Innovation (Kelly), Children's Hospital Research Institute of Manitoba, Department of Pediatrics & Child Health, University of Manitoba, Winnipeg, Man.; College of Pharmacy and Nutrition (Alcorn), University of Saskatchewan, Saskatoon, Sask.; Division of Pediatric Neurology (Appendino, Jacobs), Department of Pediatrics, and Alberta Children's Hospital Research Institute (Appendino, Jacobs), University of Calgary, Calgary, Alta.; Départment de pédiatrie (Bélanger), Faculté de médecine, Université Laval, Québec, Que.; Canadian Paediatric Society (Bélanger, Moore-Hepburn, 't Jong), Ottawa, Ont.; Division of Paediatric Haematology/Oncology (Crooks), Department of Pediatrics, Dalhousie University, Halifax, NS; Divisions of Emergency Medicine and Clinical Pharmacology and Toxicology (Finkelstein), Department of Pediatrics, University of Toronto, Toronto, Ont.; The Rosalind and Morris Goodman Family Pediatric Formulations Centre of the Sainte-Justine University Hospital Centre (Gilpin, Litalien), Montréal, Que.; Neurology Centre of Toronto (Lewis); Division of Pediatric Neurology (Lewis), Department of Pediatrics, University of Toronto, Toronto, Ont.; Départment de pédiatrie (Litalien), Faculté de médecine, Université de Montréal, Montréal, Que.; Division of Paediatric Medicine (Moore-Hepburn), Department of Paediatrics, University of Toronto, Toronto, Ont.; Department of Pediatrics and School of Population and Public Health (Oberlander), and Division of Pediatric Hematology/Oncology/BMT (Rassekh), Department of Pediatrics, University of British Columbia, Vancouver, BC; Division of Pediatric Pharmacology (Rieder), Department of Pediatrics, University of Western Ontario, London, Ont.; Amarimed of Colorado (Shackelford), Denver, Colorado; Division of Palliative Care (Siden), Department of Pediatrics, University of British Columbia; Canuck Place (Siden), Children's Hospice, Vancouver, BC; School of Public Health (Szafron), University of Saskatchewan, Saskatoon, Sask.; Departments of Pediatrics and Pharmacology ('t Jong), Max Rady College of Medicine, University of Manitoba, Winnipeg, Man.; Children's Hospital of Eastern Ontario (Vaillancourt), Ottawa, Ont.
Michael J RiederDivision of Pediatric Neurology (Huntsman), Department of Pediatrics, and Cannabinoid Research Initiative of Saskatchewan (Huntsman, Alcorn, Szafron, Shackelford), University of Saskatchewan, Saskatoon, Sask.; Canadian Childhood Cannabinoid Clinical Trial (C4T) Consortium (Kelly, Crooks, Finkelstein, Gilpin, Oberlander, Rassekh, Repetski, Rieder, Vaillancourt); George and Fay Yee Centre for Health Care Innovation (Kelly), Children's Hospital Research Institute of Manitoba, Department of Pediatrics & Child Health, University of Manitoba, Winnipeg, Man.; College of Pharmacy and Nutrition (Alcorn), University of Saskatchewan, Saskatoon, Sask.; Division of Pediatric Neurology (Appendino, Jacobs), Department of Pediatrics, and Alberta Children's Hospital Research Institute (Appendino, Jacobs), University of Calgary, Calgary, Alta.; Départment de pédiatrie (Bélanger), Faculté de médecine, Université Laval, Québec, Que.; Canadian Paediatric Society (Bélanger, Moore-Hepburn, 't Jong), Ottawa, Ont.; Division of Paediatric Haematology/Oncology (Crooks), Department of Pediatrics, Dalhousie University, Halifax, NS; Divisions of Emergency Medicine and Clinical Pharmacology and Toxicology (Finkelstein), Department of Pediatrics, University of Toronto, Toronto, Ont.; The Rosalind and Morris Goodman Family Pediatric Formulations Centre of the Sainte-Justine University Hospital Centre (Gilpin, Litalien), Montréal, Que.; Neurology Centre of Toronto (Lewis); Division of Pediatric Neurology (Lewis), Department of Pediatrics, University of Toronto, Toronto, Ont.; Départment de pédiatrie (Litalien), Faculté de médecine, Université de Montréal, Montréal, Que.; Division of Paediatric Medicine (Moore-Hepburn), Department of Paediatrics, University of Toronto, Toronto, Ont.; Department of Pediatrics and School of Population and Public Health (Oberlander), and Division of Pediatric Hematology/Oncology/BMT (Rassekh), Department of Pediatrics, University of British Columbia, Vancouver, BC; Division of Pediatric Pharmacology (Rieder), Department of Pediatrics, University of Western Ontario, London, Ont.; Amarimed of Colorado (Shackelford), Denver, Colorado; Division of Palliative Care (Siden), Department of Pediatrics, University of British Columbia; Canuck Place (Siden), Children's Hospice, Vancouver, BC; School of Public Health (Szafron), University of Saskatchewan, Saskatoon, Sask.; Departments of Pediatrics and Pharmacology ('t Jong), Max Rady College of Medicine, University of Manitoba, Winnipeg, Man.; Children's Hospital of Eastern Ontario (Vaillancourt), Ottawa, Ont.
Alan ShackelfordDivision of Pediatric Neurology (Huntsman), Department of Pediatrics, and Cannabinoid Research Initiative of Saskatchewan (Huntsman, Alcorn, Szafron, Shackelford), University of Saskatchewan, Saskatoon, Sask.; Canadian Childhood Cannabinoid Clinical Trial (C4T) Consortium (Kelly, Crooks, Finkelstein, Gilpin, Oberlander, Rassekh, Repetski, Rieder, Vaillancourt); George and Fay Yee Centre for Health Care Innovation (Kelly), Children's Hospital Research Institute of Manitoba, Department of Pediatrics & Child Health, University of Manitoba, Winnipeg, Man.; College of Pharmacy and Nutrition (Alcorn), University of Saskatchewan, Saskatoon, Sask.; Division of Pediatric Neurology (Appendino, Jacobs), Department of Pediatrics, and Alberta Children's Hospital Research Institute (Appendino, Jacobs), University of Calgary, Calgary, Alta.; Départment de pédiatrie (Bélanger), Faculté de médecine, Université Laval, Québec, Que.; Canadian Paediatric Society (Bélanger, Moore-Hepburn, 't Jong), Ottawa, Ont.; Division of Paediatric Haematology/Oncology (Crooks), Department of Pediatrics, Dalhousie University, Halifax, NS; Divisions of Emergency Medicine and Clinical Pharmacology and Toxicology (Finkelstein), Department of Pediatrics, University of Toronto, Toronto, Ont.; The Rosalind and Morris Goodman Family Pediatric Formulations Centre of the Sainte-Justine University Hospital Centre (Gilpin, Litalien), Montréal, Que.; Neurology Centre of Toronto (Lewis); Division of Pediatric Neurology (Lewis), Department of Pediatrics, University of Toronto, Toronto, Ont.; Départment de pédiatrie (Litalien), Faculté de médecine, Université de Montréal, Montréal, Que.; Division of Paediatric Medicine (Moore-Hepburn), Department of Paediatrics, University of Toronto, Toronto, Ont.; Department of Pediatrics and School of Population and Public Health (Oberlander), and Division of Pediatric Hematology/Oncology/BMT (Rassekh), Department of Pediatrics, University of British Columbia, Vancouver, BC; Division of Pediatric Pharmacology (Rieder), Department of Pediatrics, University of Western Ontario, London, Ont.; Amarimed of Colorado (Shackelford), Denver, Colorado; Division of Palliative Care (Siden), Department of Pediatrics, University of British Columbia; Canuck Place (Siden), Children's Hospice, Vancouver, BC; School of Public Health (Szafron), University of Saskatchewan, Saskatoon, Sask.; Departments of Pediatrics and Pharmacology ('t Jong), Max Rady College of Medicine, University of Manitoba, Winnipeg, Man.; Children's Hospital of Eastern Ontario (Vaillancourt), Ottawa, Ont.
Hal SidenDivision of Pediatric Neurology (Huntsman), Department of Pediatrics, and Cannabinoid Research Initiative of Saskatchewan (Huntsman, Alcorn, Szafron, Shackelford), University of Saskatchewan, Saskatoon, Sask.; Canadian Childhood Cannabinoid Clinical Trial (C4T) Consortium (Kelly, Crooks, Finkelstein, Gilpin, Oberlander, Rassekh, Repetski, Rieder, Vaillancourt); George and Fay Yee Centre for Health Care Innovation (Kelly), Children's Hospital Research Institute of Manitoba, Department of Pediatrics & Child Health, University of Manitoba, Winnipeg, Man.; College of Pharmacy and Nutrition (Alcorn), University of Saskatchewan, Saskatoon, Sask.; Division of Pediatric Neurology (Appendino, Jacobs), Department of Pediatrics, and Alberta Children's Hospital Research Institute (Appendino, Jacobs), University of Calgary, Calgary, Alta.; Départment de pédiatrie (Bélanger), Faculté de médecine, Université Laval, Québec, Que.; Canadian Paediatric Society (Bélanger, Moore-Hepburn, 't Jong), Ottawa, Ont.; Division of Paediatric Haematology/Oncology (Crooks), Department of Pediatrics, Dalhousie University, Halifax, NS; Divisions of Emergency Medicine and Clinical Pharmacology and Toxicology (Finkelstein), Department of Pediatrics, University of Toronto, Toronto, Ont.; The Rosalind and Morris Goodman Family Pediatric Formulations Centre of the Sainte-Justine University Hospital Centre (Gilpin, Litalien), Montréal, Que.; Neurology Centre of Toronto (Lewis); Division of Pediatric Neurology (Lewis), Department of Pediatrics, University of Toronto, Toronto, Ont.; Départment de pédiatrie (Litalien), Faculté de médecine, Université de Montréal, Montréal, Que.; Division of Paediatric Medicine (Moore-Hepburn), Department of Paediatrics, University of Toronto, Toronto, Ont.; Department of Pediatrics and School of Population and Public Health (Oberlander), and Division of Pediatric Hematology/Oncology/BMT (Rassekh), Department of Pediatrics, University of British Columbia, Vancouver, BC; Division of Pediatric Pharmacology (Rieder), Department of Pediatrics, University of Western Ontario, London, Ont.; Amarimed of Colorado (Shackelford), Denver, Colorado; Division of Palliative Care (Siden), Department of Pediatrics, University of British Columbia; Canuck Place (Siden), Children's Hospice, Vancouver, BC; School of Public Health (Szafron), University of Saskatchewan, Saskatoon, Sask.; Departments of Pediatrics and Pharmacology ('t Jong), Max Rady College of Medicine, University of Manitoba, Winnipeg, Man.; Children's Hospital of Eastern Ontario (Vaillancourt), Ottawa, Ont.
Michael SzafronDivision of Pediatric Neurology (Huntsman), Department of Pediatrics, and Cannabinoid Research Initiative of Saskatchewan (Huntsman, Alcorn, Szafron, Shackelford), University of Saskatchewan, Saskatoon, Sask.; Canadian Childhood Cannabinoid Clinical Trial (C4T) Consortium (Kelly, Crooks, Finkelstein, Gilpin, Oberlander, Rassekh, Repetski, Rieder, Vaillancourt); George and Fay Yee Centre for Health Care Innovation (Kelly), Children's Hospital Research Institute of Manitoba, Department of Pediatrics & Child Health, University of Manitoba, Winnipeg, Man.; College of Pharmacy and Nutrition (Alcorn), University of Saskatchewan, Saskatoon, Sask.; Division of Pediatric Neurology (Appendino, Jacobs), Department of Pediatrics, and Alberta Children's Hospital Research Institute (Appendino, Jacobs), University of Calgary, Calgary, Alta.; Départment de pédiatrie (Bélanger), Faculté de médecine, Université Laval, Québec, Que.; Canadian Paediatric Society (Bélanger, Moore-Hepburn, 't Jong), Ottawa, Ont.; Division of Paediatric Haematology/Oncology (Crooks), Department of Pediatrics, Dalhousie University, Halifax, NS; Divisions of Emergency Medicine and Clinical Pharmacology and Toxicology (Finkelstein), Department of Pediatrics, University of Toronto, Toronto, Ont.; The Rosalind and Morris Goodman Family Pediatric Formulations Centre of the Sainte-Justine University Hospital Centre (Gilpin, Litalien), Montréal, Que.; Neurology Centre of Toronto (Lewis); Division of Pediatric Neurology (Lewis), Department of Pediatrics, University of Toronto, Toronto, Ont.; Départment de pédiatrie (Litalien), Faculté de médecine, Université de Montréal, Montréal, Que.; Division of Paediatric Medicine (Moore-Hepburn), Department of Paediatrics, University of Toronto, Toronto, Ont.; Department of Pediatrics and School of Population and Public Health (Oberlander), and Division of Pediatric Hematology/Oncology/BMT (Rassekh), Department of Pediatrics, University of British Columbia, Vancouver, BC; Division of Pediatric Pharmacology (Rieder), Department of Pediatrics, University of Western Ontario, London, Ont.; Amarimed of Colorado (Shackelford), Denver, Colorado; Division of Palliative Care (Siden), Department of Pediatrics, University of British Columbia; Canuck Place (Siden), Children's Hospice, Vancouver, BC; School of Public Health (Szafron), University of Saskatchewan, Saskatoon, Sask.; Departments of Pediatrics and Pharmacology ('t Jong), Max Rady College of Medicine, University of Manitoba, Winnipeg, Man.; Children's Hospital of Eastern Ontario (Vaillancourt), Ottawa, Ont.
Geert W 't JongDivision of Pediatric Neurology (Huntsman), Department of Pediatrics, and Cannabinoid Research Initiative of Saskatchewan (Huntsman, Alcorn, Szafron, Shackelford), University of Saskatchewan, Saskatoon, Sask.; Canadian Childhood Cannabinoid Clinical Trial (C4T) Consortium (Kelly, Crooks, Finkelstein, Gilpin, Oberlander, Rassekh, Repetski, Rieder, Vaillancourt); George and Fay Yee Centre for Health Care Innovation (Kelly), Children's Hospital Research Institute of Manitoba, Department of Pediatrics & Child Health, University of Manitoba, Winnipeg, Man.; College of Pharmacy and Nutrition (Alcorn), University of Saskatchewan, Saskatoon, Sask.; Division of Pediatric Neurology (Appendino, Jacobs), Department of Pediatrics, and Alberta Children's Hospital Research Institute (Appendino, Jacobs), University of Calgary, Calgary, Alta.; Départment de pédiatrie (Bélanger), Faculté de médecine, Université Laval, Québec, Que.; Canadian Paediatric Society (Bélanger, Moore-Hepburn, 't Jong), Ottawa, Ont.; Division of Paediatric Haematology/Oncology (Crooks), Department of Pediatrics, Dalhousie University, Halifax, NS; Divisions of Emergency Medicine and Clinical Pharmacology and Toxicology (Finkelstein), Department of Pediatrics, University of Toronto, Toronto, Ont.; The Rosalind and Morris Goodman Family Pediatric Formulations Centre of the Sainte-Justine University Hospital Centre (Gilpin, Litalien), Montréal, Que.; Neurology Centre of Toronto (Lewis); Division of Pediatric Neurology (Lewis), Department of Pediatrics, University of Toronto, Toronto, Ont.; Départment de pédiatrie (Litalien), Faculté de médecine, Université de Montréal, Montréal, Que.; Division of Paediatric Medicine (Moore-Hepburn), Department of Paediatrics, University of Toronto, Toronto, Ont.; Department of Pediatrics and School of Population and Public Health (Oberlander), and Division of Pediatric Hematology/Oncology/BMT (Rassekh), Department of Pediatrics, University of British Columbia, Vancouver, BC; Division of Pediatric Pharmacology (Rieder), Department of Pediatrics, University of Western Ontario, London, Ont.; Amarimed of Colorado (Shackelford), Denver, Colorado; Division of Palliative Care (Siden), Department of Pediatrics, University of British Columbia; Canuck Place (Siden), Children's Hospice, Vancouver, BC; School of Public Health (Szafron), University of Saskatchewan, Saskatoon, Sask.; Departments of Pediatrics and Pharmacology ('t Jong), Max Rady College of Medicine, University of Manitoba, Winnipeg, Man.; Children's Hospital of Eastern Ontario (Vaillancourt), Ottawa, Ont.
Régis VaillancourtDivision of Pediatric Neurology (Huntsman), Department of Pediatrics, and Cannabinoid Research Initiative of Saskatchewan (Huntsman, Alcorn, Szafron, Shackelford), University of Saskatchewan, Saskatoon, Sask.; Canadian Childhood Cannabinoid Clinical Trial (C4T) Consortium (Kelly, Crooks, Finkelstein, Gilpin, Oberlander, Rassekh, Repetski, Rieder, Vaillancourt); George and Fay Yee Centre for Health Care Innovation (Kelly), Children's Hospital Research Institute of Manitoba, Department of Pediatrics & Child Health, University of Manitoba, Winnipeg, Man.; College of Pharmacy and Nutrition (Alcorn), University of Saskatchewan, Saskatoon, Sask.; Division of Pediatric Neurology (Appendino, Jacobs), Department of Pediatrics, and Alberta Children's Hospital Research Institute (Appendino, Jacobs), University of Calgary, Calgary, Alta.; Départment de pédiatrie (Bélanger), Faculté de médecine, Université Laval, Québec, Que.; Canadian Paediatric Society (Bélanger, Moore-Hepburn, 't Jong), Ottawa, Ont.; Division of Paediatric Haematology/Oncology (Crooks), Department of Pediatrics, Dalhousie University, Halifax, NS; Divisions of Emergency Medicine and Clinical Pharmacology and Toxicology (Finkelstein), Department of Pediatrics, University of Toronto, Toronto, Ont.; The Rosalind and Morris Goodman Family Pediatric Formulations Centre of the Sainte-Justine University Hospital Centre (Gilpin, Litalien), Montréal, Que.; Neurology Centre of Toronto (Lewis); Division of Pediatric Neurology (Lewis), Department of Pediatrics, University of Toronto, Toronto, Ont.; Départment de pédiatrie (Litalien), Faculté de médecine, Université de Montréal, Montréal, Que.; Division of Paediatric Medicine (Moore-Hepburn), Department of Paediatrics, University of Toronto, Toronto, Ont.; Department of Pediatrics and School of Population and Public Health (Oberlander), and Division of Pediatric Hematology/Oncology/BMT (Rassekh), Department of Pediatrics, University of British Columbia, Vancouver, BC; Division of Pediatric Pharmacology (Rieder), Department of Pediatrics, University of Western Ontario, London, Ont.; Amarimed of Colorado (Shackelford), Denver, Colorado; Division of Palliative Care (Siden), Department of Pediatrics, University of British Columbia; Canuck Place (Siden), Children's Hospice, Vancouver, BC; School of Public Health (Szafron), University of Saskatchewan, Saskatoon, Sask.; Departments of Pediatrics and Pharmacology ('t Jong), Max Rady College of Medicine, University of Manitoba, Winnipeg, Man.; Children's Hospital of Eastern Ontario (Vaillancourt), Ottawa, Ont.
Cannabinoid Research Initiative of Saskatchewan and the Canadian Childhood Cannabinoid Clinical Trial (C4T) Consortium
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Health PolicyCanadaCannabinoidsChildGovernment RegulationHumansMedical MarijuanaPractice Guidelines as TopicCannabinoidsMedical Marijuana
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.